Published in Gastroenterology on December 21, 2009
Derivation and Validation of a Scoring System to Stratify Risk for Advanced Colorectal Neoplasia in Asymptomatic Adults: A Cross-sectional Study. Ann Intern Med (2015) 3.45
Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: a prospective cohort study. J Clin Oncol (2012) 2.22
A model to determine colorectal cancer risk using common genetic susceptibility loci. Gastroenterology (2015) 2.14
A score to estimate the likelihood of detecting advanced colorectal neoplasia at colonoscopy. Gut (2014) 1.83
Understanding the contribution of family history to colorectal cancer risk and its clinical implications: A state-of-the-science review. Cancer (2016) 1.55
Genetic pathways, prevention, and treatment of sporadic colorectal cancer. Oncoscience (2014) 1.07
Family history of colorectal cancer in BRAF p.V600E-mutated colorectal cancer cases. Cancer Epidemiol Biomarkers Prev (2013) 1.05
Screening participation for people at increased risk of colorectal cancer due to family history: a systematic review and meta-analysis. Fam Cancer (2013) 0.96
Screening practices of unaffected people at familial risk of colorectal cancer. Cancer Prev Res (Phila) (2011) 0.95
Hereditary and common familial colorectal cancer: evidence for colorectal screening. Dig Dis Sci (2014) 0.92
Cost-effectiveness of colorectal cancer screening in high-risk Spanish patients: use of a validated model to inform public policy. Cancer Epidemiol Biomarkers Prev (2010) 0.92
Multiplicity and molecular heterogeneity of colorectal carcinomas in individuals with serrated polyposis. Am J Surg Pathol (2013) 0.91
Family history of colorectal cancer: clinicians' preventive recommendations and patient behavior. Prev Chronic Dis (2011) 0.89
Influence of miRNA-106b and miRNA-135a on butyrate-regulated expression of p21 and Cyclin D2 in human colon adenoma cells. Genes Nutr (2015) 0.86
Colorectal cancer in the young, many questions, few answers. World J Gastrointest Oncol (2016) 0.86
Racial and ethnic variations in the effects of family history of colorectal cancer on screening compliance. Gastroenterology (2013) 0.86
Activating mutation in MET oncogene in familial colorectal cancer. BMC Cancer (2011) 0.85
Advanced Stage Colorectal Cancer in Persons Younger Than 50 Years not Associated With Longer Duration of Symptoms or Time to Diagnosis. Clin Gastroenterol Hepatol (2016) 0.84
Cost-effectiveness of family history-based colorectal cancer screening in Australia. BMC Cancer (2014) 0.83
Family history and the natural history of colorectal cancer: systematic review. Genet Med (2015) 0.80
Role of tumour molecular and pathology features to estimate colorectal cancer risk for first-degree relatives. Gut (2014) 0.80
Screening patterns in patients with a family history of colorectal cancer often do not adhere to national guidelines. Dig Dis Sci (2013) 0.80
Colorectal cancer screening in patients at moderately increased risk due to family history. World J Gastrointest Oncol (2012) 0.80
Cell-based Immunotherapy for Colorectal Cancer with Cytokine-induced Killer Cells. Immune Netw (2016) 0.79
Interest and informational preferences regarding genomic testing for modest increases in colorectal cancer risk. Public Health Genomics (2014) 0.78
Identification of rare germline copy number variations over-represented in five human cancer types. Mol Cancer (2015) 0.78
Prevalence and Penetrance of Major Genes and Polygenes for Colorectal Cancer. Cancer Epidemiol Biomarkers Prev (2016) 0.78
Familial colorectal cancer: a review. World J Gastroenterol (2014) 0.77
Familial colorectal cancer screening: When and what to do? World J Gastroenterol (2015) 0.77
The discriminatory capability of existing scores to predict advanced colorectal neoplasia: a prospective colonoscopy study of 5,899 screening participants. Sci Rep (2016) 0.75
Family history of colorectal cancer and its impact on survival in patients with resected stage III colon cancer: results from NCCTG Trial N0147 (Alliance). J Gastrointest Oncol (2017) 0.75
Effect of lentivirus-mediated shRNA inactivation of HK1, HK2, and HK3 genes in colorectal cancer and melanoma cells. BMC Genet (2016) 0.75
Mutation analysis of 13 driver genes of colorectal cancer-related pathways in Taiwanese patients. World J Gastroenterol (2016) 0.75
The impact of family history on the risk of colorectal neoplasia: don't change the guidelines just yet! Dig Dis Sci (2012) 0.75
Positive family history of colorectal cancer in a general practice setting [FRIDA.Frankfurt]: study protocol of a of a cross-sectional study. BMC Cancer (2015) 0.75
Reproductive history and risk of colorectal adenocarcinoma in parous women: a Nordic population-based case-control study. Br J Cancer (2016) 0.75
Shared health characteristics in Hispanic colorectal cancer patients and their primary social support person following primary diagnosis. Psychooncology (2015) 0.75
Perspective: Chemoprevention of colorectal neoplasia: Translating scientific promise into clinical practice. J Carcinog (2011) 0.75
Guanylyl cyclase C signaling axis and colon cancer prevention. World J Gastroenterol (2016) 0.75
KSR1 and EPHB4 Regulate Myc and PGC1β To Promote Survival of Human Colon Tumors. Mol Cell Biol (2016) 0.75
Determining the familial risk distribution of colorectal cancer: a data mining approach. Fam Cancer (2016) 0.75
In vitro fermentation of nuts results in the formation of butyrate and c9,t11 conjugated linoleic acid as chemopreventive metabolites. Eur J Nutr (2015) 0.75
Comparative Evaluation of Preliminary Screening Methods for Colorectal Cancer in a Mass Program. Dig Dis Sci (2017) 0.75
MicroRNA-455 suppresses the oncogenic function of HDAC2 in human colorectal cancer. Braz J Med Biol Res (2017) 0.75
Targeting tumor multicellular aggregation through IGPR-1 inhibits colon cancer growth and improves chemotherapy. Oncogenesis (2017) 0.75
Cancer statistics, 2008. CA Cancer J Clin (2008) 86.74
Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology (2008) 15.86
Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology (2003) 14.67
Patterns of colorectal cancer screening uptake among men and women in the United States. Cancer Epidemiol Biomarkers Prev (2006) 6.67
Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst (1994) 6.27
A prospective study of family history and the risk of colorectal cancer. N Engl J Med (1994) 6.12
A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol (2001) 4.61
Cancer screening in the United States, 2007: a review of current guidelines, practices, and prospects. CA Cancer J Clin (2007) 4.09
Cancer risk in relatives of patients with common colorectal cancer. Ann Intern Med (1993) 2.61
Relative and absolute risk of colorectal cancer for individuals with a family history: a meta-analysis. Eur J Cancer (2005) 2.16
New standards and enhanced utility for family health history information in the electronic health record: an update from the American Health Information Community's Family Health History Multi-Stakeholder Workgroup. J Am Med Inform Assoc (2008) 2.14
Colon cancer screening. Gastroenterology (2000) 2.01
Familiality of cancer in Utah. Cancer Res (1994) 1.80
Genetic distances between the Utah Mormons and related populations. Am J Hum Genet (1984) 1.79
Biomedical databases: protecting privacy and promoting research. Trends Biotechnol (2003) 1.66
A genealogical assessment of heritable predisposition to aneurysms. J Neurosurg (2003) 1.60
Identification of excess clustering of coronary heart diseases among extended pedigrees in a genealogical population database. Am Heart J (2006) 1.60
Utah family-based analysis: past, present and future. Hum Hered (2007) 1.50
Inbreeding in the Utah Mormons: an evaluation of estimates based on pedigrees, isonymy, and migration matrices. Ann Hum Genet (1989) 1.46
Underestimation of relative risks by standardized incidence ratios for AIDS-related cancers. Ann Epidemiol (2008) 1.33
Familial risk and colorectal cancer screening health beliefs and attitudes in an insured population. Prev Med (2007) 1.21
Familial colorectal adenocarcinoma from the Swedish Family-Cancer Database. Int J Cancer (2001) 1.20
Lobular breast cancer: excess familiality observed in the Utah Population Database. Int J Cancer (2005) 1.20
Patient interest in recording family histories of cancer via the Internet. Genet Med (2008) 1.19
Extracolonic cancers associated with hereditary nonpolyposis colorectal cancer in the Utah Population Database. Am J Gastroenterol (2006) 1.17
Identification and study of Utah pseudo-isolate populations-prospects for gene identification. Am J Med Genet A (2005) 0.92
Low cancer incidence and mortality in Utah. Cancer (1977) 0.87
Genetic analysis of the Utah population: a comparison of STR and VNTR loci. Hum Biol (2000) 0.79
ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med (2013) 22.73
Quality in the technical performance of colonoscopy and the continuous quality improvement process for colonoscopy: recommendations of the U.S. Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol (2002) 6.63
Implementing genomic medicine in the clinic: the future is here. Genet Med (2013) 4.89
Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology (2006) 4.57
The Electronic Medical Records and Genomics (eMERGE) Network: past, present, and future. Genet Med (2013) 4.37
Serrated lesions of the colorectum: review and recommendations from an expert panel. Am J Gastroenterol (2012) 4.22
Hereditary and familial colon cancer. Gastroenterology (2010) 4.15
Genome-wide association study identifies three loci associated with melanoma risk. Nat Genet (2009) 3.89
Accuracy of administrative data for identifying patients with pneumonia. Am J Med Qual (2005) 3.43
Classifying free-text triage chief complaints into syndromic categories with natural language processing. Artif Intell Med (2005) 3.37
Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. CA Cancer J Clin (2006) 3.21
Automation of a problem list using natural language processing. BMC Med Inform Decis Mak (2005) 3.20
Building a robust, scalable and standards-driven infrastructure for secondary use of EHR data: the SHARPn project. J Biomed Inform (2012) 2.97
Health benefits and cost-effectiveness of primary genetic screening for Lynch syndrome in the general population. Cancer Prev Res (Phila) (2010) 2.86
Natural language processing to extract medical problems from electronic clinical documents: performance evaluation. J Biomed Inform (2005) 2.80
A two-step model for colon adenoma initiation and progression caused by APC loss. Cell (2009) 2.80
Genome-wide association study identifies three new melanoma susceptibility loci. Nat Genet (2011) 2.29
A policy model to evaluate the benefits, risks and costs of warfarin pharmacogenomic testing. Pharmacoeconomics (2010) 2.19
HOXB13 is a susceptibility gene for prostate cancer: results from the International Consortium for Prostate Cancer Genetics (ICPCG). Hum Genet (2012) 2.18
NCCN clinical practice guidelines in oncology. Colorectal cancer screening. J Natl Compr Canc Netw (2010) 2.13
Pharmacogenetic testing of CYP2C9 and VKORC1 alleles for warfarin. Genet Med (2008) 2.05
Effectiveness of topic-specific infobuttons: a randomized controlled trial. J Am Med Inform Assoc (2008) 1.97
A combined genomewide linkage scan of 1,233 families for prostate cancer-susceptibility genes conducted by the international consortium for prostate cancer genetics. Am J Hum Genet (2005) 1.96
Performance and utilization of an emergency department electronic screening tool for pneumonia. JAMA Intern Med (2013) 1.95
An international effort towards developing standards for best practices in analysis, interpretation and reporting of clinical genome sequencing results in the CLARITY Challenge. Genome Biol (2014) 1.95
Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology (2006) 1.89
Maximum-likelihood estimation of recent shared ancestry (ERSA). Genome Res (2011) 1.88
Incorporation of pharmacogenomics into routine clinical practice: the Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline development process. Curr Drug Metab (2014) 1.88
Shared predispositions of parkinsonism and cancer: a population-based pedigree-linked study. Arch Neurol (2012) 1.87
Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nat Genet (2013) 1.85
Pooled genome linkage scan of aggressive prostate cancer: results from the International Consortium for Prostate Cancer Genetics. Hum Genet (2006) 1.70
Normalization and standardization of electronic health records for high-throughput phenotyping: the SHARPn consortium. J Am Med Inform Assoc (2013) 1.64
Identification of excess clustering of coronary heart diseases among extended pedigrees in a genealogical population database. Am Heart J (2006) 1.60
Meta association of colorectal cancer confirms risk alleles at 8q24 and 18q21. Cancer Epidemiol Biomarkers Prev (2009) 1.60
Crossing the omic chasm: a time for omic ancillary systems. JAMA (2013) 1.59
Risk of colorectal cancer and adenomas in the families of patients with adenomas: a population-based study in Utah. Cancer (2013) 1.56
Description and pilot results from a novel method for evaluating return of incidental findings from next-generation sequencing technologies. Genet Med (2013) 1.55
Clinician perspectives about molecular genetic testing for heritable conditions and development of a clinician-friendly laboratory report. J Mol Diagn (2009) 1.54
Evidence for an inherited predisposition to lumbar disc disease. J Bone Joint Surg Am (2011) 1.53
Electronic medical records and personalized medicine. Hum Genet (2011) 1.52
Comparing natural language processing tools to extract medical problems from narrative text. AMIA Annu Symp Proc (2005) 1.51
Evidence-based decision support for neurological diagnosis reduces errors and unnecessary workup. J Child Neurol (2013) 1.50
Intention to undergo colonoscopy screening among relatives of colorectal cancer cases: a theory-based model. Ann Behav Med (2014) 1.49
Rapid deployment of an electronic disease surveillance system in the state of Utah for the 2002 Olympic Winter Games. Proc AMIA Symp (2002) 1.46
Evaluation of Medical Problem Extraction from Electronic Clinical Documents Using MetaMap Transfer (MMTx). Stud Health Technol Inform (2005) 1.45
Longitudinal assessment of the nevus phenotype in a melanoma kindred. J Invest Dermatol (2004) 1.44
Empiric evidence for a genetic contribution to predisposition to surgical site infection. Wound Repair Regen (2013) 1.43
Leveraging the electronic health record to implement genomic medicine. Genet Med (2012) 1.42
Randomized controlled trial of an automated problem list with improved sensitivity. Int J Med Inform (2008) 1.41
Guidelines for colonoscopy surveillance after cancer resection: a consensus update by the American Cancer Society and US Multi-Society Task Force on Colorectal Cancer. CA Cancer J Clin (2006) 1.33
Opportunities for genomic clinical decision support interventions. Genet Med (2013) 1.31
Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium. Cancer Epidemiol Biomarkers Prev (2009) 1.29
Exploiting missing clinical data in Bayesian network modeling for predicting medical problems. J Biomed Inform (2007) 1.28
Forecasting daily patient volumes in the emergency department. Acad Emerg Med (2008) 1.28
A genealogical assessment of heritable predisposition to asthma mortality. Am J Respir Crit Care Med (2007) 1.25
Evidence for an inherited predisposition contributing to the risk for rotator cuff disease. J Bone Joint Surg Am (2009) 1.21
Multilevel research and the challenges of implementing genomic medicine. J Natl Cancer Inst Monogr (2012) 1.21
Compelling evidence for a prostate cancer gene at 22q12.3 by the International Consortium for Prostate Cancer Genetics. Hum Mol Genet (2007) 1.20
Lobular breast cancer: excess familiality observed in the Utah Population Database. Int J Cancer (2005) 1.20
Frequency of familial colon cancer and hereditary nonpolyposis colorectal cancer (Lynch syndrome) in a large population database. Fam Cancer (2005) 1.20
Lynch syndrome screening implementation: business analysis by a healthcare system. Am J Manag Care (2011) 1.19
Hamartomatous polyposis syndromes. Best Pract Res Clin Gastroenterol (2009) 1.18
Significant evidence for a heritable contribution to cancer predisposition: a review of cancer familiality by site. BMC Cancer (2012) 1.18
Common familial colorectal cancer linked to chromosome 7q31: a genome-wide analysis. Cancer Res (2008) 1.17
Extracolonic cancers associated with hereditary nonpolyposis colorectal cancer in the Utah Population Database. Am J Gastroenterol (2006) 1.17
Further delineation of Kabuki syndrome in 48 well-defined new individuals. Am J Med Genet A (2005) 1.17
Significant linkage evidence for a predisposition gene for pelvic floor disorders on chromosome 9q21. Am J Hum Genet (2009) 1.16
Localization of a prostate cancer predisposition gene to an 880-kb region on chromosome 22q12.3 in Utah high-risk pedigrees. Cancer Res (2006) 1.16
Phenotypic characteristics and risk of cancer development in hyperplastic polyposis: case series and literature review. Am J Gastroenterol (2004) 1.14
Comparison of compliance for colorectal cancer screening and surveillance by colonoscopy based on risk. Genet Med (2011) 1.13
Abdominal desmoid in familial adenomatous polyposis presenting as a pancreatic cystic lesion. Fam Cancer (2005) 1.13
Adenomatous polyposis coli control of C-terminal binding protein-1 stability regulates expression of intestinal retinol dehydrogenases. J Biol Chem (2006) 1.13
Ethical, legal, and social implications of incorporating genomic information into electronic health records. Genet Med (2013) 1.11
Infobuttons and classification models: a method for the automatic selection of on-line information resources to fulfill clinicians' information needs. J Biomed Inform (2007) 1.10
Genetic variants in XRCC2: new insights into colorectal cancer tumorigenesis. Cancer Epidemiol Biomarkers Prev (2009) 1.10
A role for XRCC2 gene polymorphisms in breast cancer risk and survival. J Med Genet (2011) 1.10
American founder mutation for attenuated familial adenomatous polyposis. Clin Gastroenterol Hepatol (2007) 1.10
Development and early usage patterns of a consumer-facing family health history tool. AMIA Annu Symp Proc (2011) 1.10
Rapid ACCE: experience with a rapid and structured approach for evaluating gene-based testing. Genet Med (2007) 1.09
Systemic mastocytosis in a patient with Cowden syndrome. Am J Hematol (2014) 1.08
Genome-wide linkage analyses of extended Utah pedigrees identifies loci that influence recurrent, early-onset major depression and anxiety disorders. Am J Med Genet B Neuropsychiatr Genet (2005) 1.08
Integrating genetic information resources with an EHR. AMIA Annu Symp Proc (2006) 1.08
Familiality in brain tumors. Neurology (2008) 1.06
A comprehensive survey of cancer risks in extended families. Genet Med (2012) 1.06
Pediatric advance care planning. J Palliat Med (2005) 1.06
US system of oversight for genetic testing: a report from the Secretary's Advisory Committee on Genetics, Health and Society. Per Med (2008) 1.05
Population-based prevalence of CDKN2A mutations in Utah melanoma families. J Invest Dermatol (2006) 1.05
Population-based analysis of prognostic factors and survival in familial melanoma. J Clin Oncol (2005) 1.04
A multivariate time series approach to modeling and forecasting demand in the emergency department. J Biomed Inform (2008) 1.04
Electronic screening of dictated reports to identify patients with do-not-resuscitate status. J Am Med Inform Assoc (2004) 1.03
Colorectal cancer surveillance behaviors among members of typical and attenuated FAP families. Am J Gastroenterol (2007) 1.03
Colorectal cancer screening. J Natl Compr Canc Netw (2013) 1.02
Evidence for a heritable component in death resulting from aortic and mitral valve diseases. Circulation (2004) 1.02